| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/06/2009 | US20090197812 Peptides for Inhibiting Transglutaminase |
| 08/06/2009 | US20090197811 Orally administered peptides to improve or prevent hepatic fibrosis |
| 08/06/2009 | US20090197810 Alpha conotoxin peptides with analgesic properties |
| 08/06/2009 | US20090197808 decreasing white blood cell proliferation; by use of recombinant human CC10 (rhCC10), also known as recombinant human uteroglobin |
| 08/06/2009 | US20090197806 Adiponectin for treatment of various disorders |
| 08/06/2009 | US20090197805 Insulin receptor antagonists and related compositions, uses and methods |
| 08/06/2009 | US20090197804 Methods and Compositions for the Prevention and Treatment of Kidney Disease |
| 08/06/2009 | US20090197803 METHODS AND COMPOSITIONS FOR MODULATING T HELPER (Th) CELL DEVELOPMENT AND FUNCTION |
| 08/06/2009 | US20090197802 Analogues of GLP-1 |
| 08/06/2009 | US20090197801 Neuritogenic peptides |
| 08/06/2009 | US20090197800 Insulin Receptor Binding Peptides with Non-Insulin Gene Activation Profiles and Uses Thereof |
| 08/06/2009 | US20090197799 Methods for preparing purified lipotides |
| 08/06/2009 | US20090197798 Synthetic anti-neuropilin 1 (NRP1) cyclic peptide containing RRXR motif |
| 08/06/2009 | US20090197797 Use of hyaluronic acid as a carrier molecule for different classes of therapeutic active agents |
| 08/06/2009 | US20090197796 Methods for treating and preventing cancers that express the hypothalamic-pituitary-gonadal axis of hormones and receptors |
| 08/06/2009 | US20090197795 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
| 08/06/2009 | US20090197794 Methods of Diagnosing and Treating an Inflammatory Response |
| 08/06/2009 | US20090197337 Methods for the production of multimeric proteins and related compositions |
| 08/06/2009 | US20090197336 Suppression of polymorphic alleles |
| 08/06/2009 | US20090197317 TSG-Like Gene |
| 08/06/2009 | US20090197289 Method for confirming a diagnosis of autism |
| 08/06/2009 | US20090197278 Antibodies to hADA2 |
| 08/06/2009 | US20090197256 Use of a fibroblast growth factor-binding protein for the treatment and diagnosis of diabetic wound healing problems |
| 08/06/2009 | US20090196945 Compositions and methods for treating bacteria |
| 08/06/2009 | US20090196937 Temperature-sensitive nano-carriers |
| 08/06/2009 | US20090196936 Hydrogel wound dressing and biomaterials formed in situ and their uses |
| 08/06/2009 | US20090196931 Therapeutic inhibitor of vascular smooth muscle cells |
| 08/06/2009 | US20090196927 Polypeptide Inhibitors of HSP27 Kinase and Uses Therefor |
| 08/06/2009 | US20090196905 Stabilization of mitochondrial membranes in ocular diseases and conditions |
| 08/06/2009 | US20090196904 Highly-mineralized osteogenic sponge compositions and uses thereof |
| 08/06/2009 | US20090196898 Stabilized, sterilized collagen scaffolds with active adjuncts attached |
| 08/06/2009 | US20090196882 Methods of producing antibodies to zalpha11 cytokine receptors |
| 08/06/2009 | US20090196878 Intestinal epithelial glucose sensor |
| 08/06/2009 | US20090196873 Methods and compositions for treating diseases targeting CDCP1 |
| 08/06/2009 | US20090196868 Methods and compositions for preventing radiation-induced pneumonitis |
| 08/06/2009 | US20090196867 Soy kefir powder and uses thereof |
| 08/06/2009 | US20090196866 Pharmaceutical composition containing an iron-binding agent |
| 08/06/2009 | US20090196865 Methods for the treatment and prevention of diseases of biological conduits |
| 08/06/2009 | US20090196863 Method of antioxidation and antioxidant-functioning water |
| 08/06/2009 | US20090196855 Artificial "arterio-venous" permeable hollow fiber capillary system |
| 08/06/2009 | US20090196853 Method of treating hepatitis virus infection with a multiphasic interferon delivery profile |
| 08/06/2009 | US20090196852 Compositions and methods for diagnosing and treating immune disorders |
| 08/06/2009 | US20090196851 Use of Transcriptome Modifying Agents and Chemotherapy or Radiotherapy Against Cancer |
| 08/06/2009 | US20090196850 Anti-Kir Combination Treatments and Methods |
| 08/06/2009 | US20090196837 Use of a rice protein hydrolysate as pigmenting active principle |
| 08/06/2009 | US20090196836 Multi-Functional, Multi-Phase Skin Care Product |
| 08/06/2009 | US20090194894 Residual solvent extraction method and microparticles produced thereby |
| 08/06/2009 | CA2854933A1 Methods and compositions using soluble klotho proteins |
| 08/06/2009 | CA2714554A1 Vaccine compositions |
| 08/06/2009 | CA2714387A1 Extracellular matrix compositions |
| 08/06/2009 | CA2713459A1 Improved antitumoral treatments |
| 08/06/2009 | CA2713358A1 Preparation of terminally-sterilized collagen that is soluble at neutral ph |
| 08/06/2009 | CA2713339A1 Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers |
| 08/06/2009 | CA2713241A1 Treatment of microbial infections |
| 08/06/2009 | CA2712964A1 Tapasin augmentation for enhanced immune response |
| 08/06/2009 | CA2712634A1 Methods and compositions using klotho-fgf fusion polypeptides |
| 08/06/2009 | CA2711207A1 Recombinant ganoderma lucidium immunomodulatory protein (rlz-8) and uses thereof |
| 08/06/2009 | CA2705369A1 Biomaterial for the controlled delivery of ingredients |
| 08/05/2009 | EP2085474A1 Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector |
| 08/05/2009 | EP2085471A2 Modified factor VIIA polypeptides |
| 08/05/2009 | EP2085470A1 FVII or FVIIa variants |
| 08/05/2009 | EP2085467A2 Lutzomyia Longipalpis polypeptides and methods of use |
| 08/05/2009 | EP2085406A1 Long lasting insulin derivatives and methods thereof |
| 08/05/2009 | EP2085109A2 Transdermal drug delivery devices having coated microprotrusions |
| 08/05/2009 | EP2085095A1 Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpart |
| 08/05/2009 | EP2085094A2 Application of aminopeptidases inhibitors and pharmaceutical preparations containing same |
| 08/05/2009 | EP2085093A1 Preparation containing highly purified botulinum toxin type a derived from infant botulism pathogen |
| 08/05/2009 | EP2085090A2 Inhibitors of DNA immunostimulatory sequence activity |
| 08/05/2009 | EP2085074A1 Drug microparticles |
| 08/05/2009 | EP2085073A1 Drug microparticles |
| 08/05/2009 | EP2085072A1 Drug microparticles |
| 08/05/2009 | EP2084275A2 Polypeptide ligands for targeting cartilage and methods of use thereof |
| 08/05/2009 | EP2084274A2 Modified coagulation factor ix polypeptides and use thereof for treatment |
| 08/05/2009 | EP2084184A1 ILT-2 (LIRl ) VARIANTS WITH INCREASED AFFINITY FOR MHC CLASS I MOLECULES |
| 08/05/2009 | EP2084183A1 Pegylated pth as pth receptor modulators and uses thereof |
| 08/05/2009 | EP2084181A1 A method and preparations for the diagnosis and therapy of multiple sclerosis and immune demyelinating polyneuropathy |
| 08/05/2009 | EP2084178A2 Peptide-cytotoxic conjugates |
| 08/05/2009 | EP2084177A2 Isolation of osteoinductive proteins |
| 08/05/2009 | EP2083866A2 Lipidized interferon and uses thereof |
| 08/05/2009 | EP2083855A1 Use of measles virus nucleoprotein for treating atherosclerosis |
| 08/05/2009 | EP2083850A2 Methods and compositions for stabilizing prostate specific antigen |
| 08/05/2009 | EP2083849A2 Apparatus and method for treating obesity using neurotoxins in conjuction with bariatric procedures |
| 08/05/2009 | EP2083848A1 Method of treatment and prophylaxis |
| 08/05/2009 | EP2083847A2 Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of allergies |
| 08/05/2009 | EP2083846A2 N-terminal fgf variants having increased receptor selectivity and uses thereof |
| 08/05/2009 | EP2083845A2 Ablative immunotherapy |
| 08/05/2009 | EP2083844A2 Hcv ns3 protease inhibitors |
| 08/05/2009 | EP2083843A2 Multifunctional carriers for the delivery of nucleic acids and methods of use thereof |
| 08/05/2009 | EP2083842A2 Analogs of ghrelin substituted at the n-terminal |
| 08/05/2009 | EP2083841A2 Treatment for age-related macular degeneration and other diseases of the eye |
| 08/05/2009 | EP2083797A1 Stable liquid compositions for treating stomatitis comprising epidermal growth factor |
| 08/05/2009 | EP2012801A4 Gemcitabine combination therapy |
| 08/05/2009 | EP2007911A4 Soluble virus-specific t-cell receptor compositions |
| 08/05/2009 | EP1846022A4 Methods for treating adhesive capsulitis |
| 08/05/2009 | EP1748783A4 Treatment or prevention of respiratory viral infections with immunomodulator compounds |
| 08/05/2009 | EP1742651A4 Adrenomedullin and adrenomedullin binding protein for ischemia/reperfusion treatment |
| 08/05/2009 | EP1737821B1 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 08/05/2009 | EP1694140B1 Peptides having an ace inhibiting effect |
| 08/05/2009 | EP1663280B1 Compositions based on T-4 immune stimulating factor ("TISF") for the treatment of red blood cells, granulocytes and platelets deficiency |
| 08/05/2009 | EP1648934B1 Pharmaceutical composition comprising cyclic somatostatin analogues |